International Society of Geriatric Oncology

www.siogconference.org

 

AML at Advanced Age: Non-Intensive Therapy with HMA (Azacitinide) May Be a Valid Option

14 views
December 31, 2019
0 Comments
Login to view comments. Click here to Login